Sign in
8-K

Current Report

Niagen Bioscience, Inc. Filed Acc 0001628280-25-036445

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading cdxc-20250725.htm…